18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation
Radiology: Imaging Cancer · 2025
DOI: 10.1148/rycan.240096 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Radiology: Imaging Cancer, 2025. Verfasst von Jennifer Holter-Chakrabarty und 12 weiteren Autor:innen. Beteiligte Einrichtung: From the Stephenson Cancer Center, University of Oklahoma Health Sciences Center, 800 NE 10th St, Oklahoma City, OK 73104 (J.H.C., L.M., S.K.V., Z.H.…. Hauptthemen laut MEDLINE: Biomarkers, Dideoxynucleosides, Graft vs Host Disease, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, CCR NIH HHS.
Abstract (Originalsprache)
Flourine 18 fluorothymidine PET has the potential to be a valuable tool in the identification of clinical and subclinical gastrointestinal graft versus host disease (GI-GVHD) and, if validated, could serve as an imaging biomarker for GI-GVHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- From the Stephenson Cancer Center, University of Oklahoma Health Sciences Center, 800 NE 10th St, Oklahoma City, OK 73104 (J.H.C., L.M., S.K.V., Z.H., M.P., J.G., Y.W.); Tisch Cancer Institute, Icahn School of Medicine…
ORCID-Profile: Jennifer Holter-Chakrabarty, Sara K Vesely, Zheng Han, Joshua Glover
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- CCR NIH HHS
- National Cancer Institute
- National Institutes of Health
- Department of Health and Human Services
- National Heart, Lung, & Blood Institute
- Oklahoma Tobacco Settlement Endowment Trust
Zitieren
APA
Holter-Chakrabarty, J., McNally, L., Levine, J., Ferrara, J., Vesely, S. K., Kanakry, C. G., Garwe, T., Han, Z., Pandey, M., Glover, J., Wen, Y., Gress, R., & Williams, K. M. (2025). 18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation. Radiology: Imaging Cancer. https://doi.org/10.1148/rycan.240096
Vancouver
Holter-Chakrabarty J, McNally L, Levine J, Ferrara J, Vesely SK, Kanakry CG, et al. 18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation. Radiology: Imaging Cancer. 2025. doi:10.1148/rycan.240096
BibTeX
@article{HolterChakrabarty2025,
author = {Holter-Chakrabarty, Jennifer and McNally, Lacey and Levine, John and Ferrara, James and Vesely, Sara K and Kanakry, Christopher G and Garwe, Tabitha and Han, Zheng and Pandey, Manu and Glover, Joshua and Wen, Yuejin and Gress, Ron and Williams, Kirsten M},
title = {18 F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation},
journal = {Radiology: Imaging Cancer},
year = {2025},
doi = {10.1148/rycan.240096}
}
EUVIMED